The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 6,101–6,200 of 31,469
Admiraal, W. M., Vlaar, E. M., Nierkens, V., Holleman, F., Middelkoop, B. J., Stronks, K., & van Valkengoed, I. G. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068605 · Cited by 58
The CAPN10 Gene Is Associated with Insulin Resistance Phenotypes in the Spanish Population
Sáez, M. E., González‐Sánchez, J. L., Ramírez‐Lorca, R., Martínez-Larrad, M. T., Aben, K. K. H., González, A., Morón, F. J., Ruiz, A., & Serrano‐Ríos, M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002953 · Cited by 58
Inflammatory biomarkers and telomere length in women with polycystic ovary syndrome
Pedroso, D. C. C., Furtado, C. L. M., Kogure, G. S., Meola, J., Okuka, M., Silva, C., Calado, R. T., Ferriani, R. A., Keefe, D. L., & dos Reis, R. M. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.10.035 · Cited by 58
Angulo, P., George, J., Day, C. P., Vanni, E., Russell, L., Cruz, A. C. D., Liaquat, H., Mezzabotta, L., Lee, E. Y., & Bugianesi, E. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.11.035 · Cited by 58
Tajiri, Y., Kato, T., Nakayama, H., & Yamada, K. (2009) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2009.0043 · Cited by 58
Rhee, E., Oh, K. W., Yun, E., et al. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03344160 · Cited by 58
A Randomized Trial of the Effect of Statin and Fibrate Therapy on Arterial Function in CKD
Dogra, G. K., Irish, A. B., Chan, D. C., et al. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.03.003 · Cited by 58
Analysis of the visual system in Friedreich ataxia
Seyer, L. A., Galetta, K. M., Wilson, J. A., et al. (2013) · Journal of Neurology · doi:10.1007/s00415-013-6978-z · Cited by 58
Sert, A., Aypar, E., Pirgon, Ö., Yılmaz, H. S., Odabaş, D., & Tolu, İ. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.03.056 · Cited by 58
Association of Adiponectin, Resistin, and Vascular Inflammation
Choi, H. Y., Kim, S., Yang, S. J., Yoo, H. J., Seo, J. A., Kim, S. G., Kim, N. H., Baik, S. H., Choi, D. S., & Choi, K. M. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.220673 · Cited by 58
Dodevska, M. S., Sobajic, S. S., Djordjević, P., Dimitrijevic-Sreckovic, V. S., Spasojević‐Kalimanovska, V., & Djordjevic, B. I. (2015) · European Journal of Nutrition · doi:10.1007/s00394-015-0831-3 · Cited by 63
Reid, T. J., Jin, Z., Shen, W., Reyes-Vidal, C. M., Fernandez, J. C., Bruce, J. N., Kostadinov, J., Post, K. D., & Freda, P. U. (2015) · Pituitary · doi:10.1007/s11102-015-0657-2 · Cited by 58
Gonzales, G. F., & Gonzales, C. (2014) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.12.039 · Cited by 60
Orchard, T. J., Temprosa, M. G., & Goldberg, R. (2005) · ACC Current Journal Review · doi:10.1016/j.accreview.2005.06.031 · Cited by 58
Harano, Y., Miyawaki, T., Nabiki, J., Shibachi, M., Adachi, T., IKEDA, M., Ueda, F., & Nakano, T. (2006) · Endocrine Journal · doi:10.1507/endocrj.53.173 · Cited by 58
Inaba, M., Otani, Y., Nishimura, K., Takaha, N., Okuyama, Ä., Koga, M., Azuma, J., Kawase, I., & Kasayama, S. (2004) · Metabolism · doi:10.1016/j.metabol.2004.07.010 · Cited by 58
Fat-Free Mass Depletion and Inflammation in Patients with Bronchiectasis
Olveira, G., Olveira, C., Gaspar, I., et al. (2012) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2012.08.013 · Cited by 58
Long-Chain Omega-3 Fatty Acids and Blood Pressure
Liu, J. C., Conklin, S. M., Manuck, S. B., Yao, J. K., & Muldoon, M. F. (2011) · American Journal of Hypertension · doi:10.1038/ajh.2011.120 · Cited by 57
Kwak, M., Kim, D., Chung, G. E., Kim, W. K., Kim, Y. J., & Yoon, J. (2014) · Liver International · doi:10.1111/liv.12552 · Cited by 59
Fernandes, J., Vogt, J. A., & Wolever, T. M. S. (2012) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2012.98 · Cited by 58
Gujral, U. P., Narayan, K. M. V., Kahn, S. E., & Kanaya, A. M. (2013) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2013.10.002 · Cited by 60
Long-term effects of diabetes during pregnancy on the offspring
Wróblewska‐Seniuk, K., Wender-Ożegowska, E., & Szczapa, J. (2009) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2009.00507.x · Cited by 61
Preatherosclerosis and Adiponectin Subfractions in Obese Adolescents
Mangge, H., Almer, G., Haj‐Yahya, S., Pilz, S., Gasser, R. N. A., Möller, R., & Horejsi, R. (2008) · Obesity · doi:10.1038/oby.2008.439 · Cited by 59
Physiological modulation of circulating FGF21: relevance of free fatty acids and insulin
Mai, K., Bobbert, T., Groth, C., Aßmann, A., Meinus, S., Kraatz, J., Andres, J., Arafat, A. M., Pfeiffer, A. F. H., Möhlig, M., et al. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00020.2010 · Cited by 58
Sakurai, M., Nakamura, K., Miura, K., Takamura, T., Yoshita, K., Sasaki, S., Nagasawa, S., Morikawa, Y., Ishizaki, M., Kido, T., et al. (2013) · Journal of Diabetes Investigation · doi:10.1111/jdi.12033 · Cited by 58
Rey-López, J. P., Carvalho, H. B., de Moraes, A. C. F., Ruiz, J. R., Sjöstróm, M., Marcos, A., Polito, A., Gottrand, F., Μanios, Y., Kafatos, A., et al. (2013) · Sleep Medicine · doi:10.1016/j.sleep.2013.07.021 · Cited by 59
A population-based study of associations between preeclampsia and later cardiovascular risk factors
Alsnes, I. V., Janszky, I., Forman, M. R., VATTEN, L. J., & Økland, I. (2014) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2014.06.026 · Cited by 58
High iron level in early pregnancy increased glucose intolerance
Zein, S., Rachidi, S., Awada, S., Osman, M., Al‐Hajje, A., Shami, N., Sharara, I., Cheikh-Ali, K., Salameh, P., & Hininger‐Favier, I. (2014) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2014.09.004 · Cited by 61
Relation between fibroblast growth factor–21, adiposity, metabolism, and weight reduction
Mai, K., Schwarz, F., Bobbert, T., Andres, J., Aßmann, A., Pfeiffer, A. F. H., & Spranger, J. (2010) · Metabolism · doi:10.1016/j.metabol.2010.02.016 · Cited by 58
Omentin and chemerin and their association with obesity in women with polycystic ovary syndrome
Güzel, E. Ç., Celik, C., Abalı, R., Küçükyalçın, V., Celik, E., GÜZEL, M., & Yılmaz, M. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2014.888412 · Cited by 58
Naderali, E. K., Pickavance, L. C., Wilding, J. P. H., & Williams, G. (2001) · Clinical Science · doi:10.1042/cs1000635 · Cited by 59
Gannagé‐Yared, M., Klammt, J., Chouery, É., Corbani, S., Megarbane, H. A. R., Ghoch, J. A., Choucair, N., Pfäffle, R. W., & Mégarbané, A. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0701 · Cited by 59
Red blood cell distribution width and diabetes-associated complications
Magri, C. J., & Fava, S. (2013) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2013.10.012 · Cited by 58
Xu, W., Bi, Y., Sun, Z., Li, J., Guo, L., Yang, T., Wu, G., Shi, L., Feng, Z., Qiu, L., et al. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12293 · Cited by 59
Elmslie, J. L., Porter, R., Joyce, P. R., Hunt, P. J., Shand, B. I., & Scott, R. S. (2009) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670802534341 · Cited by 58
Karolkiewicz, J., Michalak, E., Pospieszna, B., Deskur-Śmielecka, E., Nowak, A., & Pilaczyńska-Szczȩśniak, Ł. (2008) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2008.09.001 · Cited by 60
Oxidative Stress in Non-Obese Women with Polycystic Ovarian Syndrome
Bitla, A. R. R. (2014) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2014/8125.4530 · Cited by 58
Association between heart rate recovery and severity of obstructive sleep apnea syndrome
Maeder, M. T., Münzer, T., Rickli, H., Schoch, O. D., Korte, W. C., Hürny, C., & Ammann, P. (2007) · Sleep Medicine · doi:10.1016/j.sleep.2007.08.016 · Cited by 60
do Prado, W. L., de Piano, A., Lazaretti‐Castro, M., de Mello, M. T., Stella, S. G., Tufik, S., do Nascimento, C. M. O., Oyama, L. M., Lofrano‐Prado, M. C., Tock, L., et al. (2009) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-009-0082-6 · Cited by 59
Mitochondrial Function and Insulin Resistance in Overweight and Normal-Weight Children
Fleischman, A., Kron, M., Systrom, D. M., Hrovat, M. I., & Grinspoon, S. K. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1590 · Cited by 59
Muellenbach, E. A., Diehl, C. J., Teachey, M. K., Lindborg, K. A., Archuleta, T. L., Harrell, N. B., Andersen, G., Somoza, V., Hasselwander, O., Matuschek, M., et al. (2008) · Metabolism · doi:10.1016/j.metabol.2008.05.018 · Cited by 58
Liver Fat Change in Obese Children After a 1‐year Nutrition‐behavior Intervention
Pozzato, C., Verduci, E., Scaglioni, S., et al. (2010) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3181d70468 · Cited by 58
Francque, S., Verrijken, A., Mertens, I. L., Hubens, G., Marck, E. V., Pelckmans, P. A., Michielsen, P. P., & Gaal, L. V. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.134 · Cited by 58
Large Waist but Low Body Mass Index: The Metabolic Syndrome in Australian Aboriginal Children
Sellers, E. A. C., Singh, G., & Sayers, S. M. (2008) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2008.02.006 · Cited by 59
Separate and overlapping metabolic functions of LXRα and LXRβ in C57Bl/6 female mice
Korach-André, M., Parini, P., Larsson, L., Arner, A., Steffensen, K. R., & Gustafsson, J.-Α. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00184.2009 · Cited by 58
Studen, K. B., Šebeštjen, M., Pfeifer, M., & Preželj, J. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0709 · Cited by 58
Plamboeck, A., Veedfald, S., Deacon, C. F., Hartmann, B., Wettergren, A., Svendsen, L. B., Meisner, S., Hovendal, C. P., Knop, F. K., Vilsbøll, T., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0264 · Cited by 59
Association between circulating adiponectin levels and polycystic ovarian syndrome
Mirza, S. S., Shafique, K., Shaikh, A. R., Khan, N. A., & Qureshi, M. A. (2014) · Journal of Ovarian Research · doi:10.1186/1757-2215-7-18 · Cited by 58
Barreiro, P., Pineda, J. A., Rallón, N. I., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir113 · Cited by 58
Singh, P. K., Hota, D., Dutta, P. R., Sachdeva, N. K., Chakrabarti, A., Srinivasan, A., Singh, I., & Bhansali, A. K. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1720 · Cited by 59
Levels of Serum Ceruloplasmin Associate With Pediatric Nonalcoholic Fatty Liver Disease
Nobili, V., Siotto, M., Bedogni, G., Ravà, L., Pietrobattista, A., Panera, N., Alisi, A., & Squitti, R. (2012) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e31827aced4 · Cited by 61
Spyridaki, E. C., Simos, P. G., Avgoustinaki, P. D., Dermitzaki, E., Venihaki, M., Bardos, A. N., & Margioris, A. N. (2014) · British Journal Of Nutrition · doi:10.1017/s0007114514002207 · Cited by 57
Chung, S., Park, C. W., Shin, S. J., Lim, J. H., Chung, H. W., Youn, D., Kim, H., Kim, B. S., Lee, J. H., Kim, G., et al. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp472 · Cited by 58
Han, J. C., Muehlbauer, M. J., Cui, H. N., Newgard, C. B., & Haqq, A. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0127 · Cited by 58
Abnormal Aldosterone Physiology and Cardiometabolic Risk Factors
Vaidya, A., UNDERWOOD, P. C., Hopkins, P. N., Jeunemaı̂tre, X., Ferri, C., Williams, G. H., & Adler, G. K. (2013) · Hypertension · doi:10.1161/hypertensionaha.111.00662 · Cited by 58
Subsequent Pregnancy After Gestational Diabetes Mellitus
Kwak, S. H., Kim, H. S., Choi, S. H., Lim, S. K., Cho, Y. M., Park, K. S., Jang, H. C., Kim, M. Y., Cho, N. H., & Metzger, B. E. (2008) · Diabetes Care · doi:10.2337/dc08-0384 · Cited by 60
Huh, J. H., Lee, K. J., Lim, J. S., Lee, M. Y., Park, H. J., Kim, M. Y., Kim, J. W., Chung, C. H., Shin, J. Y., Kim, H. S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143222 · Cited by 59
Abdelmegeed, M. A., Choi, Y., Ha, S.-K., & Song, B. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.12.016 · Cited by 57
Chang, C., Wu, C., Su, W., Shih, K., Tarng, D., Chou, C., Chen, T.-Y., Kor, C., & Wu, H.-M. (2015) · Scientific Reports · doi:10.1038/srep10096 · Cited by 59
Lanzi, C. R., Perdicaro, D. J., Antoniolli, A., Fontana, A., Miatello, R. M., Bottini, R., & Prieto, M. A. V. (2016) · Food & Function · doi:10.1039/c5fo01065a · Cited by 58
Lomenick, J. P., Buchowski, M. S., & Shoemaker, A. H. (2016) · Obesity · doi:10.1002/oby.21493 · Cited by 58
Yajnik, C. S., Katre, P. A., Joshi, S. M., Kumaran, K., Bhat, D., Lubree, H., MEMANE, N. S., Kinare, A. S., Pandit, A. N., Bhave, S. A., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3602-z · Cited by 62
Disrupted Brain Connectivity Patterns in Patients with Type 2 Diabetes
Cui, Y., Li, S., Gu, H., Hu, Y.-Z., Liang, X.-N., Lu, C., Cai, Y., Wang, C.-X., Yang, Y., & Teng, G. (2016) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4858 · Cited by 57
Takeno, K., Tamura, Y., Kawaguchi, M., Kakehi, S., Watanabe, T., Funayama, T., Furukawa, Y., Kaga, H., Yamamoto, R., Kim, M., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1650 · Cited by 59
Kramer, C. K., Zinman, B., Choi, H., & Retnakaran, R. R. (2016) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000270 · Cited by 59
Urinary bisphenol A is associated with insulin resistance and obesity in reproductive‐aged women
Hong, S., Sung, Y., Hong, Y. S., Ha, E., Jeong, K., Chung, H., & Lee, H. (2016) · Clinical Endocrinology · doi:10.1111/cen.13270 · Cited by 61
Alsanea, S., & Liu, D. (2017) · Pharmaceutical Research · doi:10.1007/s11095-017-2230-3 · Cited by 58
Jia, K., Zheng, Y.-J., Zhang, Y., Liu, J.-H., Jiao, R., Pan, Y., & Kong, L. (2017) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2017.08.004 · Cited by 59
Li, J., Sasaki, G. Y., Dey, P., Chitchumroonchokchai, C., Labyk, A. N., McDonald, J. D., Kim, J. B., & Bruno, R. S. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.10.016 · Cited by 58
Lee, W., Rhee, E., Chang, Y., Sohn, C. I., Shin, H. C., Ryu, S., & Lee, W. (2017) · Metabolism · doi:10.1016/j.metabol.2017.11.014 · Cited by 58
Barstad, L. H., Júlíusson, P. B., Johnson, L. K., Hertel, J. K., Lekhal, S., & Hjelmesaeth, J. S. (2018) · BMC Pediatrics · doi:10.1186/s12887-018-1057-3 · Cited by 64
Deng, T., Zhang, Y., Wu, Y., et al. (2018) · Toxicology Letters · doi:10.1016/j.toxlet.2018.03.004 · Cited by 58
Santos, A. P., Santos, A. C., Castro, C., Raposo, L., Pereira, S. S., Torres, I., Henrique, R., Cardoso, H., & Monteiro, M. P. (2018) · Cancers · doi:10.3390/cancers10090293 · Cited by 60
Gorgey, A. S., Khalil, R. E., Gill, R. S., Gater, D. R., Lavis, T. D., Cardozo, C. P., & Adler, R. A. (2019) · Journal of Neurotrauma · doi:10.1089/neu.2018.6136 · Cited by 58
Nettore, I. C., Rocca, C., Mancino, G., Albano, L., Amelio, D., Grande, F., Puoci, F., Pasqua, T., Desiderio, S., Mazza, R., et al. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.03.019 · Cited by 62
Therapeutic Mechanisms of Herbal Medicines Against Insulin Resistance: A Review
Li, J., Bai, L., Wei, F., Zhao, J., Wang, D., Xiao, Y., Yan, W., & Wei, J. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00661 · Cited by 61
Fassler, C. S., Pinney, S. E., Xie, C., Biro, F. M., & Pinney, S. M. (2019) · Environmental Research · doi:10.1016/j.envres.2019.108558 · Cited by 59
Jiang, Y., Tan, S., Wang, Z., Guo, Z., Li, Q., & Wang, J. (2019) · Journal of Exercise Science & Fitness · doi:10.1016/j.jesf.2019.08.003 · Cited by 61
Shishehgar, F., Mirmiran, P., Rahmati, M., Tohidi, M., & Ramezani Tehrani, F. (2019) · BMC Endocrine Disorders · doi:10.1186/s12902-019-0420-1 · Cited by 59
Nokoff, N., Scarbro, S. L., Moreau, K. L., Zeitler, P. S., Nadeau, K. J., Juarez‐Colunga, E., & Kelsey, M. M. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz029 · Cited by 58
Singer, R. A., Arnes, L., Cui, Y., Wang, J., Gao, Y., Guney, M. A., Burnum-Johnson, K., Rabadán, R., Ansong, C. K., Orr, G., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.09.013 · Cited by 58
Wu, S. F., Hooten, N. N., Freeman, D. W., Mode, N. A., Zonderman, A. B., & Evans, M. K. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02398-6 · Cited by 59
Du, S., Lv, Y., Li, N., Huang, X., Liu, X., Li, H., Wang, C., & Jia, Y. (2020) · Drug Delivery · doi:10.1080/10717544.2020.1775722 · Cited by 58
Li, N., Liu, Y., Papandonatos, G. D., Calafat, A. M., Eaton, C. B., Kelsey, K. T., Cecil, K. M., Kalkwarf, H. J., Yolton, K. A., Lanphear, B. P., et al. (2021) · Environment International · doi:10.1016/j.envint.2020.106344 · Cited by 60
Moran, L., Noakes, M., Clifton, P. M., & Norman, R. J. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1188 · Cited by 58
Higashiura, K., Ura, N., Ohata, J., Togashi, N., Takagi, S., Saitoh, S., Murakami, H., Takagawa, Y., & Shimamoto, K. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02165.x · Cited by 56
Kriemler, S., Manser-Wenger, S., Zahner, L., Braun‐Fahrländer, C., Schindler, C., & Puder, J. J. (2008) · Diabetologia · doi:10.1007/s00125-008-1067-z · Cited by 58
Mamabolo, R. L., Alberts, M., Levitt, N. S., de Waal, H. A. D., & Steyn, N. P. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.02073.x · Cited by 59
Muscular strength and markers of insulin resistance in European adolescents: the HELENA Study
Jiménez‐Pavón, D., Ortega, F. B., Valtueña, J., Castro‐Piñero, J., Gómez‐Martínez, S., Zaccaria, M., Gottrand, F., Molnár, D., Sjöstróm, M., González‐Gross, M., et al. (2011) · European Journal of Applied Physiology · doi:10.1007/s00421-011-2216-5 · Cited by 59
Furuta, H., Furuta, M., Sanke, T., Ekawa, K., Hanabusa, T., Nishi, M., Sasaki, H., & Nanjo, K. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.8.8776 · Cited by 58
The threshold value for insulin resistance on homeostasis model assessment of insulin sensitivity
Nakai, Y., Fukushima, M., Nakaishi, S., Kishimoto, H., Seino, Y., Nagasaka, S., Sakai, M., & Taniguchi, A. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00712_3.x · Cited by 58
Socioeconomic Disparities in Insulin Resistance: Results From the Princeton School District Study
Goodman, E., Daniels, S. R., & Dolan, L. M. (2006) · Psychosomatic Medicine · doi:10.1097/01.psy.0000249732.96753.8f · Cited by 58
The emergence of type 2 diabetes in childhood
Ehtisham, S., & Barrett, T. G. (2004) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/000456304322664654 · Cited by 58
Oral Glucosamine in Doses Used to Treat Osteoarthritis Worsens Insulin Resistance
Pham, T., Cornea, A., Jenkins, A. J., et al. (2007) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e318065bdbe · Cited by 58
Relation of insulin resistance to left ventricular hypertrophy and diastolic dysfunction in obesity
Mureddu, G., Greco, R., Rosato, G., Cella, A., Vaccaro, O., Contaldo, F., & SIMONE, G. D. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800596 · Cited by 58
Araújo‐Vilar, D., Lattanzi, G., González‐Méndez, B., Costa‐Freitas, A. T., Prieto, D., Columbaro, M., Mattioli, E., Victoria, B., Martínez‐Sánchez, N., Рамазанова, А. Р., et al. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2008.059485 · Cited by 58
Bacha, F. F., Gungor, N., & Arslanian, S. A. (2008) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2007.11.044 · Cited by 57
Waist circumference is the main determinant of elevated C-reactive protein in metabolic syndrome
Nakamura, H., Ito, H., Egami, Y., Kaji, Y., Maruyama, T., Koike, G., Jingu, S., & Harada, M. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.09.004 · Cited by 59
Lawlor, D. A., Ben‐Shlomo, Y., Ebrahim, S. B. J., Smith, G. D., Stansfeld, S. A., YARNELL, J. W. G., & Gallacher, J. (2005) · BMJ · doi:10.1136/bmj.38377.616921.f7 · Cited by 58
Hostility, Race, and Glucose Metabolism in Nondiabetic Individuals
Surwit, R. S., Williams, R. B., Siegler, I. C., Lane, J. D., Helms, M. J., Applegate, K. L., Zucker, N. L., Feinglos, M. N., McCaskill, C. C., & Barefoot, J. C. (2002) · Diabetes Care · doi:10.2337/diacare.25.5.835 · Cited by 58
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
